Records containing: Migraine
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-01-02A Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy, and Safety of Oral Frovatriptan in the Prevention on Menstrually-related Migraine (MRM) Headaches in a 'Difficult to Treat' Population
-
CLINICAL_TRIALS study record update · 2023-12-29Efficacy of Flunarizine Vs Amitriptyline in Prophylaxis of Migraine Prophylaxis
-
CLINICAL_TRIALS study record update · 2023-12-26Value of Intravenous Fluids in the Emergent Treatment of Pediatric Migraine
-
CLINICAL_TRIALS study record update · 2023-12-22Randomized, Two-way, Two-period, Single Oral Dose, Open-label, Crossover, Bioequivalence Study to Compare Ibuprofen/ Paracetamol Tablets (200mg Ibuprofen/ 500mg Paracetamol) Versus Nuromol® Tablets (200mg Ibuprofen/ 500mg Paracetamol) in Healthy Subjects Under Fasting Condition
-
CLINICAL_TRIALS study record update · 2023-12-15Establishment of a Human Electrophysiological Model to Quantify the Calcitonin Gene-related Peptide (CGRP)-Related Axon Reflex of Trigeminal Afferents and Its Evaluation as a Clinical Tool to Assess and Predict Treatment Effects of Migraine Prophylaxis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-12-14A Single-center, Open-label, Clinical Effect Observational Study to Evaluate the Safety and Effectiveness of Reducing the Frequency of Migraine Onset Through Clinical Application of Elexir (Trigeminal Nerve Electrical Stimulator) in Migraine Patients
-
CLINICAL_TRIALS study record update · 2023-12-14A Multicenter, Double-blind, Parallel Design, Randomized, Placebo Controlled, Post-marketing Clinical Trial to Evaluate the Efficacy and Safety of Elexir (Trigeminal Nerve Electrical Stimulator) in Migraine Patients.
-
CLINICAL_TRIALS study record update · 2023-12-08Open-label Randomized Controlled Trial for the Effects of Continuous Ethinylestradiol/Levonorgestrel (30/150 μg/Day) Compared With Vitamin E (400 IU/Day) in the Treatment of Menstrually-related Migraine and Migraine During Perimenopause
-
CLINICAL_TRIALS study record update · 2023-12-08Unwinding Anxiety for Migraine: Pilot
-
CLINICAL_TRIALS study record update · 2023-12-06A Randomized, Double-blind, Placebo-controlled Clinical Trial Evaluated the Safety and Tolerability, Pharmacokinetic and Pharmacodynamics Profile, and Immunogenicity of a Single Dose of JS010 Injection in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2023-12-06Comparison of Efficacy Between Combination of Amitriptyline-propranolol and Pizotifen for Migraine Prophylaxis: A Single-blind Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2023-12-04Molecular Stratification of Signaling Pathways Underlying Migraine Pathophysiology.
-
CLINICAL_TRIALS study record update · 2023-11-28A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY3451838 in Adults With Treatment-Resistant Migraine
-
CLINICAL_TRIALS study record update · 2023-11-28Migraine Headache Mitigation Utilizing Avulux Color Filtering Lenses
-
CLINICAL_TRIALS study record update · 2023-11-27Mindfulness and Mechanisms of Pain Processing in Adults With Migraines
-
CLINICAL_TRIALS study record update · 2023-11-18Presence of Signs of Central Sensitization in Episodic and Chronic Migraine - a Cross Sectional Study
-
CLINICAL_TRIALS study record update · 2023-11-01Muscle Function and Strength Training of the Neck and Shoulder in Migraine and Tension-type Headache Patients.
-
CLINICAL_TRIALS study record update · 2023-10-24A Double-blind Randomised Controlled Study to Evaluate the Effectiveness of Orally-dosed Palmitoylethanolamide (PEA) Compared to Placebo for Reducing Pain Severity and Duration of Migraines in Otherwise Healthy Participants Aged 18 Years and Older.
-
CLINICAL_TRIALS study record update · 2023-10-18Zolmitriptane as Prophylactic Therapy Childhood Migraine
-
CLINICAL_TRIALS study record update · 2023-10-17Bilateral DLPC tDCS: a New Potential Neuromodulatory Strategy in Drug-resistant Migraine
-
CLINICAL_TRIALS study record update · 2023-10-13Melatonin for Adolescent Migraine Prevention Study (The MAP Study).
-
CLINICAL_TRIALS study record update · 2023-10-12Testing the Reliability and Validity of a New Measure for Illness-related Distress.
-
CLINICAL_TRIALS study record update · 2023-10-11Role of Volumetric MRI Brain in Evaluation of Migraine
-
CLINICAL_TRIALS study record update · 2023-10-10An Open-Label, Long-Term Study to Assess the Safety and Efficacy of AXS-07 (MoSEIC™ Meloxicam and Rizatriptan) for the Acute Treatment of Migraine in Adults
-
CLINICAL_TRIALS study record update · 2023-10-06An Open-label, Single-dose, Pharmacokinetic Study to Evaluate IV Eptinezumab in Children and Adolescents With Migraine, Followed by an Optional, Multiple-dose, Open-label Extension Period